Positive Long-Term Data for Lombard Medical’s Aorfix™ Endovascular Stent Graft System Confirms Sustained Performance in the Most Challenging Anatomies
December 05, 2016 06:00 ET
|
Lombard Medical, Inc.
OXFORDSHIRE, United Kingdom, Dec. 05, 2016 (GLOBE NEWSWIRE) -- Lombard Medical, Inc. (NASDAQ:EVAR), a medical device company focused on endovascular aneurysm repair (EVAR) of abdominal aortic...
Multi-Centre Early Experience and Data Presented on Lombard Medical’s Altura® Endovascular Stent Graft at the 43rd Annual VEITHsymposium™
November 21, 2016 12:03 ET
|
Lombard Medical, Inc.
OXFORDSHIRE, United Kingdom, Nov. 21, 2016 (GLOBE NEWSWIRE) -- Lombard Medical, Inc. (NASDAQ:EVAR), a medical device company focused on endovascular aneurysm repair (EVAR) of abdominal aortic...
Lombard Medical Receives NASDAQ Notice of Bid Price Deficiency
November 15, 2016 16:00 ET
|
Lombard Medical, Inc.
OXFORDSHIRE, United Kingdom, Nov. 15, 2016 (GLOBE NEWSWIRE) -- Lombard Medical, Inc. (NASDAQ:EVAR), a medical device company focused on Endovascular Repair (EVAR) of abdominal aortic aneurysms...
Lombard Medical Announces Scientific Presentations on Aorfix™ and Altura® Endovascular Stent Grafts at the 43nd Annual VEITHsymposium™
November 14, 2016 06:00 ET
|
Lombard Medical, Inc.
OXFORDSHIRE, United Kingdom, Nov. 14, 2016 (GLOBE NEWSWIRE) -- Lombard Medical, Inc. (NASDAQ:EVAR), a medical device company focused on endovascular aneurysm repair (EVAR) of abdominal aortic...
Lombard Medical Reports 2016 Third Quarter, Nine-Month Financial Results
October 27, 2016 16:00 ET
|
Lombard Medical, Inc.
IRVINE, Calif., Oct. 27, 2016 (GLOBE NEWSWIRE) -- Lombard Medical, Inc. (NASDAQ:EVAR), a medical device company focused on endovascular aneurysm repair (EVAR) of abdominal aortic aneurysms (AAAs),...
Lombard Medical Reports 2016 Second Quarter, Six-Month Financial Results and Provides Update on Strategic Initiatives
August 22, 2016 16:00 ET
|
Lombard Medical, Inc.
IRVINE, Calif., Aug. 22, 2016 (GLOBE NEWSWIRE) -- Lombard Medical, Inc. (NASDAQ:EVAR), a medical device company focused on endovascular aneurysm repair (EVAR) of abdominal aortic aneurysms (AAAs),...
Lombard Medical Reschedules 2016 Second Quarter, Six-Month Financial Results Release and Conference Call Date to August 22 to Provide Complete Information on Operational Initiatives
August 12, 2016 16:00 ET
|
Lombard Medical, Inc.
IRVINE, Calif., Aug. 12, 2016 (GLOBE NEWSWIRE) -- Lombard Medical, Inc. (Nasdaq:EVAR), a medical device company focused on Endovascular Aortic Repair (EVAR) of abdominal aortic aneurysms (AAAs),...
Lombard Medical Announces 2016 Second Quarter, Six-Month Financial Results Release and Conference Call Date
August 08, 2016 06:00 ET
|
Lombard Medical, Inc.
IRVINE, Calif., Aug. 08, 2016 (GLOBE NEWSWIRE) -- Lombard Medical, Inc. (Nasdaq:EVAR), a medical device company focused on Endovascular Aortic Repair (EVAR) of abdominal aortic aneurysms (AAAs),...
Lombard Medical Expands European Launch of its New Altura® Endograft System
July 06, 2016 06:00 ET
|
Lombard Medical, Inc.
IRVINE, Calif., July 06, 2016 (GLOBE NEWSWIRE) -- Lombard Medical, Inc. (NASDAQ:EVAR), a medical device company focused on Endovascular Aneurysm Repair (EVAR) of abdominal aortic aneurysms (AAAs),...
Lombard Medical Announces First Commercial Use of its New IntelliFlex™ LP Delivery System for the Aorfix™ Abdominal Aortic Aneurysm Endovascular Stent Graft
June 30, 2016 06:00 ET
|
Lombard Medical, Inc.
IRVINE, Calif., June 30, 2016 (GLOBE NEWSWIRE) -- Lombard Medical, Inc. (NASDAQ:EVAR), a medical device company focused on Endovascular Aneurysm Repair (EVAR) of abdominal aortic aneurysms (AAAs),...